Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC2A1 | P11166 | 1/20 | 0.47 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.43 |
| ▸ | SCN5A | Q14524 | 1/20 | 0.40 |
| ▸ | BTK | Q06187 | 4/20 | 0.35 |
| ▸ | TOP1 | P11387 | 1/20 | 0.34 |
| ▸ | DYRK3 | O43781 | 1/20 | 0.33 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.33 |
| ▸ | SRPK1 | Q96SB4 | 1/20 | 0.33 |
| ▸ | CSNK1G1 | Q9HCP0 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27366399 | 0.90 | KCNH2 (0.44) | SLC2A1KCNH2SCN5ABTKTOP1 | |
| Hydrochloric Acid SCHEMBL7504569 | 0.90 | KCNH2 (0.43) | SLC2A1KCNH2SCN5ABTKTOP1 | |
| SCHEMBL27350832 | 0.87 | KCNH2 (0.41) | SLC2A1KCNH2SCN5ABTKTOP1 | |
| Hydrochloric Acid SCHEMBL7507501 | 0.86 | KCNH2 (0.41) | SLC2A1KCNH2SCN5ABTKTOP1 | |
| SCHEMBL8561869 | 0.86 | DYRK3 (0.44) | KCNH2SCN5ABTKTOP1DYRK3 | |
| SCHEMBL8562871 | 0.86 | KCNH2 (0.41) | SLC2A1KCNH2SCN5ABTK | |
| SCHEMBL8576029 | 0.85 | KCNH2 (0.49) | SLC2A1KCNH2SCN5A | |
| SCHEMBL8567918 | 0.85 | KCNH2 (0.49) | SLC2A1KCNH2SCN5A | |
| SCHEMBL8576032 | 0.85 | KCNH2 (0.49) | SLC2A1KCNH2SCN5A | |
| SCHEMBL14497283 | 0.85 | SCN5A (0.43) | KCNH2SCN5ABTKTOP1DYRK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0871628-A1 | QUINOLIZINONE TYPE COMPOUNDS | Abbott Laboratories (US) | 1998-10-21 | — | — | EP | disclosed |